EMAS position statement: menopause symptom management in women with dyslipidemias

Amsterdam, 4 April, 2020 – A new clinical guide by the European Menopause and Andropause Society (EMAS) published in the journal Maturitas provides an evidence-based approach to the menopausal symptom management in women with dyslipidemias (abnormal lipid levels), as well as to the management of dyslipidemias in postmenopausal women. Dyslipidemias are quite common disorders, constituting…

Details

Management of depressive symptoms in peri- and post-menopausal women: EMAS Clinical Guide

Amsterdam, 7 November 2019 – A new position statement by the European Menopause and Andropause Society (EMAS) published in the journal Maturitas summarises the evidence about management of depression at the menopause. Globally, the total number of people with depression exceeds 300 million with a 70% greater incidence in women. The perimenopause is considered to…

Details